STONEPINE CAPITAL, L.P. purchased 2.4% of their position (89.84K shares) of NOVELION THERAPEUTICS INC. on the open market
Open‑market purchase worth $67.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/26/2019ACC: 0001567619-19-022304
10% Owner
Since Sep 2019
+89.84K
Net shares
Net buyer
$67.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
89.84K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+89.84K
Price / share
$0.75
Trade value
$67.03K
% of position
2.4%
11/22/2019
3.80M→3.89M
Total
Net shares
+89.84K
Net value
$67.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/22/2019 | P · Purchase | +89.84K | $0.75 | $67.03K | 2.4% | 3.80M | 3.89M |
| Total | +89.84K | $67.03K | ||||||
Derivative Transactions0
No derivative transactions reported